Stimulating brain cells with light

October 26, 2012

For the time being, this is basic research but the long term objective is to find new ways of treating Parkinson's disease. This increasingly common disease is caused by degeneration of the brain cells producing signal substance dopamine.

Many experiments have been conducted on both animals and humans, transplanting healthy to make up for the lack of dopamine, but it is difficult to study what happens to the transplant.

"We don't know how the new nerve cells behave once they have been transplanted into the brain. Do they connect to the surrounding cells as they should, and can they function normally and produce dopamine as they should? Can we use to reinforce dopamine production? These are the issues we want to investigate with optogenetics", says Professor Merab Kokaia.

Optogenetics allows scientists to control certain cells in the brain using light, leaving other cells unaffected. In order to do this, the relevant cells are equipped with for a special light-sensitive protein. The protein makes the cells react when they are illuminated with light from a thin optic fibre which is also implanted in the brain. The cells can then be "switched on" when they are illuminated.

"If we get signals as a response to light from the host brain, we know that they come from the transplanted cells since they are the only ones to carry the light-sensitive protein. This gives us a much more specific way of studying the brain's reactions than inserting an electrode, which is the current method.

With an electrode, we do not know whether the electric signals that are detected come from "new" or "old" ", explains Merab Kokaia.

The work will be conducted on modelling Parkinson's disease. The transplanted cells will be derived from skin from an adult human and will have been "reprogrammed" as nerve cells.

Merab Kokaia will be collaborating with neuro-researchers Malin Parmar and Olle Lindvall on the project.

The three Lund researchers have received a grant of USD 75 000 from the Michael J. Fox Foundation, started by actor Michael J. Fox and dedicated to Parkinson's research.

The light-sensitive protein is obtained from a bacterium, which uses light to gain energy.

Since it is not a human , the safety checks will be extra strict if the method is to be used on humans.

"We know that this is long term research. But the methodology is interesting and it will be exciting to see what we can come up with," says Merab Kokaia.

Explore further: From stem cell to brain cell - new technique mimics the brain

Related Stories

From stem cell to brain cell - new technique mimics the brain

May 24, 2012
A new technique that converts stem cells into brain cells has been developed by researchers at Lund University. The method is simpler, quicker and safer than previous research has shown and opens the doors to a shorter route ...

Stem cells reverse disease in a model of Parkinson's disease

May 16, 2011
In a new study to be published in the Journal of Clinical Investigation, researchers compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and ...

Dopamine controls formation of new brain cells

April 8, 2011
(PhysOrg.com) -- A study of the salamander brain has led researchers at Karolinska Institutet to discover a hitherto unknown function of the neurotransmitter dopamine. In an article published in the prestigious scientific ...

Cell-replacement therapy could lead to Parkinson's treatment

November 7, 2011
(Medical Xpress) -- Researchers have developed an efficient way of making specific cells in high numbers that have worked in mice to reverse the damage caused by Parkinson’s disease and hope to be testing these cells ...

Recommended for you

Synthetic hydrogels deliver cells to repair intestinal injuries

October 23, 2017
By combining engineered polymeric materials known as hydrogels with complex intestinal tissue known as organoids - made from human pluripotent stem cells - researchers have taken an important step toward creating a new technology ...

Study reveals connection between microbiome and autoimmune disorders

October 23, 2017
Many people associate the word "bacteria" with something dirty and disgusting. Dr. Pere Santamaria disagrees. Called the microbiome, the bacteria in our bodies have all kinds of positive effects on our health, Santamaria ...

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.